Life Science Tools and Reagents

Life Science Tools and Reagents Market Outlook

The global Life Science Tools and Reagents market is projected to reach USD 60 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.5% from 2025 to 2035. This robust growth is driven by the increasing demand for advanced diagnostic tools and reagents, fueled by the rising prevalence of chronic diseases and a growing focus on personalized medicine. Moreover, the surge in research and development activities across pharmaceutical and biotechnology sectors, along with advancements in technologies such as CRISPR, genomic sequencing, and proteomics, is further intensifying the market dynamics. With the ongoing evolution of healthcare and scientific research, the life science tools and reagents market is poised for significant expansion, providing a plethora of opportunities for various stakeholders in the industry.

Growth Factor of the Market

The growth of the Life Science Tools and Reagents market is largely attributed to the increasing investments in research and development across the biopharmaceutical and biotechnology sectors. Pharmaceutical companies are focusing on drug discovery and development processes to create innovative therapies that meet the needs of the population, resulting in heightened demand for sophisticated tools and reagents. Furthermore, the integration of automation and digital technologies in laboratory processes enhances efficiency, accuracy, and productivity, making it a key factor driving the market. Additionally, the rise of personalized medicine is compelling researchers to invest in tools that enable targeted therapies, increasing the demand for specific reagents and kits. The growing focus on genomics and proteomics, along with the need for rapid and efficient diagnostic solutions, continues to propel the market forward, making it a pivotal area in the life sciences sector.

Key Highlights of the Market

• The market is expected to witness a CAGR of 8.5% from 2025 to 2035.
• North America holds the largest market share, driven by high R&D spending and advanced healthcare infrastructure.
• Increased demand for personalized medicine is significantly influencing market growth.
• The rise in chronic diseases is fueling the need for advanced diagnostics and research tools.
• Innovation in life science technologies, such as automation and digital solutions, is enhancing laboratory efficiencies.

By Product Type

Cell Biology Tools:

Cell biology tools represent a critical segment of the life science tools market, focusing on the study of cell structures, functions, and interactions. These tools are integral to various applications in research, drug discovery, and clinical diagnostics. The rising prevalence of diseases such as cancer and genetic disorders has escalated the demand for cell biology tools that aid in understanding cell behavior and pathology. Techniques such as flow cytometry, cell imaging, and cell culture systems are increasingly utilized by researchers to explore cellular mechanisms and develop novel therapeutic strategies. The continuous innovation in these tools, including the development of high-throughput screening technologies, is further driving their adoption across academic and industrial research institutions.

Molecular Biology Tools:

Molecular biology tools encompass a broad range of technologies that facilitate the study of biological processes at the molecular level. This segment is experiencing significant growth due to the rising importance of genomics and proteomics in research. Techniques such as polymerase chain reaction (PCR), gel electrophoresis, and DNA sequencing are fundamental for molecular analysis, enabling researchers to explore genetic material and understand disease mechanisms. The advent of next-generation sequencing (NGS) technologies has revolutionized the field, providing high-throughput capabilities that expedite the analysis of genetic information. As the need for precision medicine and targeted therapies increases, the demand for advanced molecular biology tools continues to surge, marking it as a key contributor to the overall market growth.

Proteomics Tools:

Proteomics tools are essential for the comprehensive study of proteins, their functions, and their interactions within biological systems. The growing interest in protein-based therapies and biomarker discovery is propelling the demand for proteomics tools, which include techniques like mass spectrometry, protein microarrays, and two-dimensional gel electrophoresis. These technologies enable researchers to identify and characterize proteins, providing insights into disease mechanisms and aiding in drug discovery processes. The shift towards personalized medicine further emphasizes the need for proteomics tools, as understanding protein expression and modification can lead to the development of targeted treatments. This segment is thus poised for substantial growth, driven by advancements in analytical technologies and increased funding for proteomic research.

Genomics Tools:

The genomics tools segment is witnessing explosive growth, primarily driven by advancements in DNA sequencing technologies and the increasing application of genomics in personalized medicine. These tools facilitate the analysis of genetic material, enabling researchers to understand genetic variations and their association with diseases. Technologies such as whole-genome sequencing, targeted sequencing, and CRISPR-based gene editing are at the forefront of genomic research, allowing for unprecedented insights into human genetics and disease mechanisms. The expansion of genomic databases and biobanks is further fueling demand, as researchers seek to integrate genomic data into clinical applications. As genomic medicine continues to evolve, the adoption of genomics tools is expected to accelerate, positioning this segment as a significant driver of market growth.

Immunology Tools:

Immunology tools are crucial for the study of immune responses and the development of vaccines and therapeutics. The increasing incidence of infectious diseases, autoimmune disorders, and allergies is driving the demand for immunology tools, which encompass a variety of assays and reagents used to analyze immune responses. Technologies such as enzyme-linked immunosorbent assays (ELISA), flow cytometry, and multiplex immunoassays are widely used in both research and clinical settings. The COVID-19 pandemic has further emphasized the importance of immunology tools, spurring innovation and investment in this field. With the ongoing research into vaccines and immunotherapies, the immunology tools segment is set to experience robust growth, contributing significantly to the life science tools and reagents market.

By Application

Drug Discovery:

The application of life science tools and reagents in drug discovery is pivotal, as it encompasses the entire process of identifying and developing new pharmaceuticals. With the increasing complexity of diseases and the demand for novel therapeutics, the reliance on advanced tools such as high-throughput screening, target validation, and in vitro testing has surged. These tools enable researchers to rapidly analyze compounds and assess their efficacy, safety, and pharmacokinetics. The integration of artificial intelligence and machine learning in drug discovery processes is further enhancing the efficiency and accuracy of these tools. Consequently, the drug discovery segment is expected to witness substantial growth, driven by the need for innovative solutions to address unmet medical needs and the rising costs associated with traditional drug development methodologies.

Research:

In the research application segment, life science tools and reagents play a crucial role in advancing scientific knowledge across various disciplines, including biology, chemistry, and pharmacology. Researchers utilize these tools for a multitude of purposes, including basic research, applied research, and clinical studies. The increasing emphasis on research and development in academia and industry is propelling the demand for high-quality reagents and instruments that facilitate experiments, data collection, and analysis. The trend towards interdisciplinary research is also driving the need for integrated solutions that combine multiple methodologies and technologies. As funding for research continues to grow and public interest in scientific advancements increases, the research application segment is poised for continued expansion in the life science tools and reagents market.

Clinical Diagnostics:

The clinical diagnostics application of life science tools and reagents is a rapidly evolving segment, particularly driven by the increasing demand for accurate and timely diagnostic solutions. Tools used in clinical diagnostics include various assays, imaging technologies, and biosensors that aid in the detection of diseases and monitoring of patient health. The growing prevalence of chronic diseases, coupled with an aging population, is intensifying the need for efficient diagnostics to facilitate early intervention and personalized treatment. Furthermore, advancements in molecular diagnostics, such as PCR and NGS, are revolutionizing the field by providing faster and more precise results. As healthcare providers increasingly adopt these advanced diagnostic solutions, the clinical diagnostics segment is expected to experience significant growth in the coming years.

Others:

Under the 'Others' category, various niche applications of life science tools and reagents contribute to the overall market dynamics. These applications may include environmental testing, food safety testing, forensic analysis, and veterinary diagnostics. The rising awareness of food safety and environmental health, combined with stringent regulatory requirements, is driving demand for high-quality testing tools in these areas. Additionally, advancements in detection technologies and the growing focus on sustainability are encouraging the development of innovative solutions that cater to these niche markets. As industries increasingly prioritize safety and compliance, the 'Others' segment is expected to foster growth and diversification within the life science tools and reagents market.

By Distribution Channel

Direct Sales:

Direct sales channels in the life science tools and reagents market allow manufacturers and suppliers to establish a direct relationship with their customers, providing personalized services and tailored solutions. This channel is particularly beneficial for specialized products that require in-depth technical knowledge and support. By engaging directly with customers, companies can better understand their needs and preferences, leading to improved product offerings and customer satisfaction. The growth of e-commerce platforms has also enhanced the efficiency of direct sales, allowing for streamlined order processing and delivery. As the demand for customized solutions continues to rise, the direct sales channel is anticipated to play a crucial role in shaping the market landscape.

Distributors:

Distributors serve as an essential link between manufacturers and end-users in the life science tools and reagents market. They provide a wide range of products from various manufacturers, allowing researchers and institutions to access multiple options in a single location. This channel is particularly advantageous for smaller laboratories and research institutions that may not have the resources to purchase directly from manufacturers. Distributors often offer value-added services such as technical support, training, and inventory management, which enhance the overall customer experience. As the demand for a diverse range of life science products continues to grow, the distributor segment is expected to witness steady growth, providing a critical infrastructure for the market.

Online Retailers:

Online retailers have revolutionized the distribution landscape for life science tools and reagents, providing researchers with convenient access to a vast array of products. The rise of e-commerce has led to increased competition among suppliers, driving down prices and improving service levels. Researchers can easily compare products, read reviews, and make informed purchasing decisions from the comfort of their laboratories. Furthermore, online retailers often offer rapid delivery options and flexible payment methods, enhancing the overall shopping experience. The ongoing digital transformation in the life sciences sector is expected to fuel the growth of online retail channels, making them a prominent avenue for purchasing tools and reagents.

Others:

The 'Others' category in distribution channels encompasses a variety of alternative sales channels that may include wholesalers, retailers, and specialty stores focusing on life science products. While these channels may not dominate the market, they provide valuable options for customers seeking specific tools and reagents. Specialty stores often cater to niche markets or specific applications, offering targeted solutions and expert advice. As the life science tools market continues to evolve, these alternative distribution channels are expected to adapt and grow, providing additional avenues for manufacturers to reach their target customers.

By End User

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are significant end-users of life science tools and reagents, utilizing them extensively in drug discovery, development, and manufacturing processes. These companies invest heavily in research and development to create innovative therapeutic solutions, which necessitates a wide range of advanced tools, including assays, reagents, and analytical instruments. The increasing focus on personalized medicine and targeted therapies compels pharmaceutical firms to adopt cutting-edge technologies that facilitate rapid experimentation and data analysis. As a result, this segment is expected to remain a vital driver of market growth, with companies continuously seeking to enhance their research capabilities and product offerings.

Academic & Research Institutes:

Academic and research institutes are key contributors to the life science tools and reagents market, as they conduct extensive research across various disciplines, including biology, biochemistry, and molecular medicine. These institutions require a diverse array of tools and reagents to support their research endeavors, from basic studies to applied research projects. The increasing funding for scientific research and the growing collaborations between academia and industry are driving demand for high-quality tools that facilitate innovative discoveries. As research initiatives continue to expand globally, academic and research institutes are anticipated to play a critical role in shaping the future of the life science tools market.

Hospitals & Diagnostic Centers:

Hospitals and diagnostic centers are essential end-users of life science tools and reagents, utilizing them for clinical diagnostics, disease monitoring, and patient management. The growing prevalence of chronic diseases and the rising demand for rapid diagnostic solutions are propelling the need for advanced diagnostic tools in these settings. Technologies such as molecular diagnostics, immunoassays, and point-of-care testing are becoming increasingly common in hospitals as they enable timely and accurate diagnosis. The ongoing efforts to improve healthcare delivery and patient outcomes further emphasize the importance of integrating innovative tools and reagents into clinical practice, driving growth in this segment.

Others:

The 'Others' category for end users includes various sectors such as environmental testing laboratories, veterinary clinics, and food safety testing facilities. These end users rely on life science tools and reagents for a range of applications, from analyzing environmental samples to ensuring food safety standards. The increasing awareness of environmental health and safety, coupled with stringent regulatory requirements, is driving demand for high-quality testing tools in these sectors. As industries prioritize compliance and sustainability, the 'Others' segment is expected to contribute to the overall growth of the life science tools and reagents market.

By Region

The North American region is currently dominating the Life Science Tools and Reagents market, accounting for approximately 40% of the global share in 2025. This substantial market presence is primarily attributed to the advanced healthcare infrastructure, high levels of R&D spending, and the presence of major pharmaceutical and biotechnology companies in the region. Moreover, the growing focus on personalized medicine and precision healthcare in North America is further accelerating the demand for innovative life science tools. The region is expected to witness a CAGR of around 8.0% from 2025 to 2035, as continuous advancements in technology and increasing regulatory support foster further growth.

Europe is another key player in the Life Science Tools and Reagents market, holding approximately 30% of the global market share in 2025. The region's focus on scientific research and technological innovation is fostering the development of advanced life science tools. Additionally, the increasing prevalence of chronic diseases and the rising emphasis on early diagnosis and treatment are further propelling demand. The Asia Pacific region is also emerging as a significant market, driven by the growing investment in healthcare infrastructure and the increasing adoption of advanced diagnostic solutions. With a projected CAGR of 9.2%, the Asia Pacific market is expected to witness rapid growth, aided by a burgeoning population and rising healthcare expenditures.

Opportunities

The Life Science Tools and Reagents market presents numerous opportunities, particularly in the realm of technological advancements. The adoption of automation and robotics in laboratories is transforming traditional workflows, enhancing efficiency and accuracy in research processes. This trend opens avenues for manufacturers to develop innovative solutions that cater to the evolving needs of researchers and healthcare professionals. Additionally, the integration of artificial intelligence and machine learning in data analysis and interpretation is revolutionizing the way experiments are conducted, providing opportunities for companies to create more sophisticated tools that streamline research efforts. Furthermore, the growing focus on personalized medicine is driving demand for tailored solutions, presenting lucrative prospects for businesses that can deliver customized reagents and tools to meet specific patient needs.

Another key opportunity in the Life Science Tools and Reagents market lies in the expanding global healthcare landscape. As emerging economies continue to invest in healthcare infrastructure and research capabilities, there is a growing demand for high-quality life science tools. Companies that can strategically position themselves in these markets stand to benefit from increased sales and market share. Collaborations between industry players and academic institutions also present significant opportunities for innovation and development, as joint efforts can lead to breakthroughs in research and the introduction of novel products. The increasing focus on sustainability and environmental health is further encouraging the development of eco-friendly tools and reagents, providing additional avenues for growth in the market.

Threats

Despite the promising growth prospects, the Life Science Tools and Reagents market also faces several threats that could potentially hinder its development. One of the primary concerns is the increasing competition among key players, which may lead to price wars and reduced profit margins. As new entrants continue to emerge in the market, established companies may need to invest in marketing and innovation to maintain their competitive edge. Additionally, the rapid pace of technological advancements necessitates continuous investment in research and development, which can strain financial resources and impact profitability. Regulatory challenges and compliance requirements in different regions can also pose significant hurdles for market players, as navigating these complexities may require additional time and resources.

Another potential threat to the market is the fluctuation in raw material prices and supply chain disruptions, which could impact production costs and product availability. The COVID-19 pandemic has highlighted the vulnerabilities in global supply chains, emphasizing the need for companies to develop resilient strategies to mitigate risks. Furthermore, the increasing scrutiny on the ethical implications of scientific research and biotechnology may lead to heightened regulations and public concerns, potentially affecting the demand for certain tools and reagents. As the market landscape evolves, companies must remain vigilant and adaptable to address these threats effectively.

Competitor Outlook

• Thermo Fisher Scientific
• Abbott Laboratories
• Illumina, Inc.
• Roche Diagnostics
• Agilent Technologies
• Pierce Biotechnology
• Merck KGaA
• PerkinElmer, Inc.
• Bio-Rad Laboratories
• GE Healthcare
• Qiagen N.V.
• Waters Corporation
• Beckman Coulter
• Lonza Group
• SABiosciences Corporation

The competitive landscape of the Life Science Tools and Reagents market is characterized by a mix of established players and emerging companies, each striving to innovate and capture market share. Major companies such as Thermo Fisher Scientific and Roche Diagnostics are at the forefront, leveraging their extensive product portfolios and strong R&D capabilities to cater to diverse customer needs. These industry leaders are focused on continuous innovation, strategic acquisitions, and partnerships to enhance their market positions and expand their product offerings. Additionally, they are increasingly investing in advanced technologies and automation to improve laboratory efficiency and accuracy, creating a competitive advantage in the rapidly evolving market.

Emerging players such as Illumina, Inc. and Qiagen N.V. are also making significant strides in the market, particularly in the genomics and molecular diagnostics segments. These companies are capitalizing on the growing demand for precision medicine and advanced diagnostic solutions, developing cutting-edge tools and reagents that meet the needs of researchers and healthcare professionals. By focusing on niche markets and specialized applications, these companies are positioning themselves as valuable contributors to the life science tools and reagents market. Furthermore, the rise of digital platforms and online retail channels is enabling both established and emerging players to reach a broader audience, driving competition and innovation across the sector.

Overall, the Life Science Tools and Reagents market is expected to continue evolving, with companies striving to adapt to changing customer demands and technological advancements. Key players are focusing on strategic collaborations, mergers, and acquisitions to bolster their capabilities and expand their market presence. As the market landscape becomes increasingly competitive, companies that prioritize innovation, customer satisfaction, and sustainability will be better positioned to thrive in this dynamic environment.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Merck KGaA
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Lonza Group
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Qiagen N.V.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Illumina, Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Beckman Coulter
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 PerkinElmer, Inc.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Waters Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Agilent Technologies
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Bio-Rad Laboratories
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Pierce Biotechnology
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 SABiosciences Corporation
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Life Science Tools and Reagents Market, By End User
    • 6.1.1 Pharmaceutical & Biotechnology Companies
    • 6.1.2 Academic & Research Institutes
    • 6.1.3 Hospitals & Diagnostic Centers
    • 6.1.4 Others
  • 6.2 Life Science Tools and Reagents Market, By Application
    • 6.2.1 Drug Discovery
    • 6.2.2 Research
    • 6.2.3 Clinical Diagnostics
    • 6.2.4 Others
  • 6.3 Life Science Tools and Reagents Market, By Product Type
    • 6.3.1 Cell Biology Tools
    • 6.3.2 Molecular Biology Tools
    • 6.3.3 Proteomics Tools
    • 6.3.4 Genomics Tools
    • 6.3.5 Immunology Tools
  • 6.4 Life Science Tools and Reagents Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributors
    • 6.4.3 Online Retailers
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Life Science Tools and Reagents Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Life Science Tools and Reagents market is categorized based on

By Product Type

• Cell Biology Tools
• Molecular Biology Tools
• Proteomics Tools
• Genomics Tools
• Immunology Tools

By Application

• Drug Discovery
• Research
• Clinical Diagnostics
• Others

By Distribution Channel

• Direct Sales
• Distributors
• Online Retailers
• Others

By End User

• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Centers
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Abbott Laboratories
• Illumina, Inc.
• Roche Diagnostics
• Agilent Technologies
• Pierce Biotechnology
• Merck KGaA
• PerkinElmer, Inc.
• Bio-Rad Laboratories
• GE Healthcare
• Qiagen N.V.
• Waters Corporation
• Beckman Coulter
• Lonza Group
• SABiosciences Corporation